Patents by Inventor Olof Karlsson

Olof Karlsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11796536
    Abstract: The present invention provides a method of assaying a sample solution for the presence of a first analyte comprising: (a) providing a sensor surface having a ligand immobilized thereto; (b) flowing the sample solution over the sensor surface; and (c) detecting the presence or absence of binding of the analyte to the ligand on the sensor surface; wherein the contact time between the sample solution and the immobilized ligand is less than 15 seconds.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: October 24, 2023
    Assignee: Cytiva Sweden AB
    Inventor: Olof Karlsson
  • Publication number: 20230228676
    Abstract: Disclosed is a method for classifying monitoring results from an analytical sensor system (20), by allowing (100) a first set of analyte sample solutions to interact with a ligand (3) and acquiring (101) a set of response data, extracting (102) at least one interaction parameter from the response data, and for each analyte sample solution providing (103) a trained machine learning algorithm with the interaction parameter(s). The trained machine learning algorithm classifies (104) each analyte sample solution based on the interaction parameter(s) into at least one quality classification group indicative of the interaction of the analyte sample solution with the ligand (3).
    Type: Application
    Filed: June 22, 2021
    Publication date: July 20, 2023
    Inventors: Tobias Soderman, Olof Karlsson, Paul E. Belcher
  • Publication number: 20220336041
    Abstract: Disclosed is a method of qualifying a subgroup of target binding biomolecules from a larger group of target binding biomolecules for analysis. A competitive immunoassay including a target protein is used to identify 100 interactions between different pairs of the target binding biomolecules and interaction profiles are generated 200. Each target binding biomolecule is allocated 300 to a bin representing an epitope family and identified bins are associated in a circular or semi-circular bin chart on a display with identified respective target binding biomolecule(s). Based on the association 400 between identified bins and identified respective target binding molecule(s) in the bin chart, a subgroup of target binding biomolecules is selected 500 for further analysis by selecting one or more of the target binding biomolecule(s) of one or more of the bins.
    Type: Application
    Filed: September 8, 2020
    Publication date: October 20, 2022
    Inventors: Fredrik Edebratt, Olof Karlsson, Anna Lager, Jens Larsson
  • Publication number: 20220336042
    Abstract: Disclosed is a method for classifying monitoring results from an analytical sensor system (20) arranged to monitor molecular interactions at a sensing surface, wherein detection curves representing progress of the molecular interactions with time are produced. The method comprises steps of: acquiring (100) a set of detection curves, fitting (101) a first mathemati- cal model to the set of detection curves; calculating (102) a set of features from the set of detection curves and fitted mathematical model; based on the calculated set of features, classifying (103) each detection curve into qual- ity classification group; and based on the classification determining which detection curves to use in kinetic analysis of the monitored molecular inter- actions.
    Type: Application
    Filed: September 29, 2020
    Publication date: October 20, 2022
    Inventors: Tobias Soderman, Olof Karlsson, Magnus Raberg, Andreas Borgstrom
  • Publication number: 20220137039
    Abstract: The present invention relates to a method for evaluation of an interaction between an analyte in a fluid sample and a ligand immobilized on a sensor surface of a biosensor, comprising the steps of providing (101) a plurality of fluid samples, each containing known concentrations of analyte providing (102) a plurality of needles and a plurality of sensor surfaces or detection spots, at least some of the sensor surfaces or detection spots having a known amount of ligand immobilized thereon, and each needle being configured to inject a fluid sample to a sensor surface or detection spots dividing (103) said plurality of fluid samples into at least two groups injecting (104) the fluid samples of a first of said groups to the sensor surfaces or detection spots by means of the needles to permit association of the analyte to the ligand monitoring (104) each sensor surface or detection spot and collecting binding data, and repeating (105) the steps of injecting fluid samples and monitoring detection spots and colle
    Type: Application
    Filed: January 17, 2022
    Publication date: May 5, 2022
    Inventor: Olof Karlsson
  • Patent number: 11255852
    Abstract: In one embodiment, the present invention relates to a method for establishing a solvent correction curve as well as using the curve for obtaining a corrected sensorgram or corrected report points from a sensorgram of an analyte. In another embodiment, the present invention provides an analytical system for studying molecular interactions, which comprises computer processing means including program code means for performing the steps of the methods. Also provided is a computer program product comprising program code means stored on a computer readable medium or carried on an electrical or optical signal for performing the steps of the methods.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: February 22, 2022
    Assignee: CYTIVA SWEDEN AB
    Inventors: Olof Karlsson, Henrik Berling
  • Patent number: 11255851
    Abstract: A system and method for evaluation of an interaction between an analyte in a fluid sample and a ligand immobilized on a sensor surface of a biosensor is provided. In one example, the system includes a plurality of needles, each being arranged to inject a fluid sample to one of sensor surfaces or detection spots. A plurality of fluid samples, each containing known concentrations of analyte, is provided. The plurality of fluid samples may be divided into at least two groups, each group having a number of fluid samples corresponding to the number of needles. The system and method is configured to perform the injections without intermediate regeneration or renewal of the immobilized ligand. Software for performing the steps of the method and a computer readable medium for storing the software are also provided.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: February 22, 2022
    Assignee: CYTIVA SWEDEN AB
    Inventor: Olof Karlsson
  • Patent number: 11047859
    Abstract: The invention relates to a method for normalization of a label-free system for calibration-free concentration analysis. The method comprises (1) providing a solution containing a control macromolecular particle of a known concentration at a pH lower than the pI of the macromolecular particle and a low ionic strength; (2) contacting the solution with a negatively charged optical sensor surface at a first flow rate to allow electrostatic binding of the macromolecular particle to the surface and obtaining a first sensorgram; (3) contacting the solution with the optical sensor surface at a second flow rate to allow electrostatic binding of the macromolecular particle to the surface and obtaining a second sensorgram; and (4) fitting the sensorgrams to a binding equation to determine a measured concentration of the control; wherein the optical sensor surface is not immobilized with a ligand for the control and the contacting steps are performed under mass transport limitations.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 29, 2021
    Assignee: CYTIVA SWEDEN AB
    Inventor: Olof Karlsson
  • Patent number: 11022609
    Abstract: The invention relates to a method for determining interaction kinetics for an analyte. The method comprises first contacting a solution containing the analyte with immobilized ligand, or analogue thereof, immobilized on an optical sensor surface; monitoring the binding of the analyte to the immobilized ligand or analogue, wherein the binding is measured as a resulting change in a property of the surface; and automatically determining the interaction kinetics, which determining step includes first defining parts of the dissociation phase that contains kinetic information for fitting. The invention further relates to an analytical system for studying molecular interactions, which system is capable of performing the novel method, as well as a computer program product for performing the steps of the method.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: June 1, 2021
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Olof Karlsson
  • Publication number: 20200348295
    Abstract: The present invention provides a method of assaying a sample solution for the presence of a first analyte comprising: (a) providing a sensor surface having a ligand immobilized thereto; (b) flowing the sample solution over the sensor surface; and (c) detecting the presence or absence of binding of the analyte to the ligand on the sensor surface; wherein the contact time between the sample solution and the immobilized ligand is less than 15 seconds.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Inventor: Olof Karlsson
  • Patent number: 10725030
    Abstract: The present invention provides a method of assaying a sample solution for the presence of a first analyte comprising: (a) providing a sensor surface having a ligand immobilized thereto; (b) flowing the sample solution over the sensor surface; and (c) detecting the presence or absence of binding of the analyte to the ligand on the sensor surface; wherein the contact time between the sample solution and the immobilized ligand is less than 15 seconds.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: July 28, 2020
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Olof Karlsson
  • Patent number: 10688087
    Abstract: A pharmaceutical composition for treatment of a pathological condition in a patient comprises, as a first component, a manganese complex of Formula I( ), and, as a second component, a non-manganese complex compound of Formula (I), optionally together with one or more physiologically acceptable carriers and/or excipients, wherein X, R, R, R, and R are as defined herein. Methods for treatment of a pathological condition in a patient, for example, a pathological condition caused by the presence of oxygen-derived free radicals, comprises administering to said patient the first component and the second component.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: June 23, 2020
    Assignee: PLEDPHARMA AB
    Inventors: Jan-Olof Karlsson, Rolf Andersson
  • Patent number: 10545090
    Abstract: A method of determining one or more interaction parameters for the interaction between an analyte and a ligand using a biosensor, which comprises the steps of: A: providing a sensor surface having the ligand immobilized thereto, B: contacting the sensor surface with a control analyte, C: registering the sensor response from binding of the control analyte to binding sites of the ligand, D: determining the control saturation response (RmaxC) for the interaction between the control analyte and the ligand, E: transforming the control saturation response (RmaxC) to an analyte saturation response (RmaxA) using the relative molar response contribution of the analyte and the control analyte.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: January 28, 2020
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Olof Karlsson
  • Publication number: 20200027529
    Abstract: Disclosed is a method for determining affinity of a biomolecule, including the steps of: determining a theoretical saturation response value (Rmax) based on known properties of the biomolecule or a similar biomolecule; providing a sensor surface having the biomolecule immobilized thereon as a ligand; contacting the sensor surface with a plurality of samples containing different concentrations of an analyte that is able to bind to the ligand; registering an equilibrium response (R) from binding of the analyte to binding sites of the ligand for each of the plurality of samples, said sensor response giving equilibrium response values for each sample; creating an equilibrium response sequence comprising the determined equilibrium response values; determining a plurality of values for a dissociation constant for the plurality of concentrations based on said equilibrium response sequence; and determining a theoretical dissociation constant at zero concentration based on the plurality of values for the dissociation
    Type: Application
    Filed: August 25, 2016
    Publication date: January 23, 2020
    Inventors: Tomoya Mitani, Robert Karlsson, Olof Karlsson
  • Patent number: 10151694
    Abstract: A method of evaluating an interaction parameter for the interaction between a plurality of analytes and a ligand using a biosensor, which comprises the steps of: A: providing a sensor surface having the ligand immobilized thereto, B: contacting the sensor surface with the plurality of analytes, C: registering a sensor response curve for each one of the plurality of analytes, D: extracting interaction parameters from each sensor response curve, E: evaluating each sensor response curve according to one or more binding behavior criteria, F: displaying the interaction parameters in a diagram, wherein interaction parameters relating to response curves meeting a binding behavior criteria are graphically distinguishable from interaction parameters relating to response curves meeting another or no binding behavior criteria.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: December 11, 2018
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Olof Karlsson
  • Patent number: 10111893
    Abstract: Methods for treatment of a pathological condition caused by oxidative stress in a patient comprise administering to the patient a mixed metal complex of a compound of Formula I, or a salt thereof, in an amount effective to reduce the oxidative stress. Pharmaceutical compositions are formed by suspending or dissolving a mixed metal complex of a compound of Formula I, or a salt thereof, in a liquid medium, optionally with one or more physiologically acceptable excipients. The mixed metals comprise calcium and manganese in a molar ratio of calcium to manganese in the range of 1-10: wherein X, R1, R2, R3, and R4 are as defined herein.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: October 30, 2018
    Assignee: PLEDPHARMA AB
    Inventors: Jan-Olof Karlsson, Karl Reineke, Tino Kurz, Rolf Andersson, Michael Hall, Christina McLaughlin, Sven Jacobsson, Jacques Näsström
  • Publication number: 20180284111
    Abstract: A system and method for evaluation of an interaction between an analyte in a fluid sample and a ligand immobilized on a sensor surface of a biosensor is provided. In one example, the system includes a plurality of needles, each being arranged to inject a fluid sample to one of sensor surfaces or detection spots. A plurality of fluid samples, each containing known concentrations of analyte, is provided. The plurality of fluid samples may be divided into at least two groups, each group having a number of fluid samples corresponding to the number of needles. The system and method is configured to perform the injections without intermediate regeneration or renewal of the immobilized ligand. Software for performing the steps of the method and a computer readable medium for storing the software are also provided.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 4, 2018
    Inventor: Olof Karlsson
  • Patent number: 10085819
    Abstract: A dental drill system is provided, comprising a drill having a drilling part with a first end configured for drilling a hole in a jaw bone and a shank part with a second end configured for connection to a drill-rotating device and a guiding sleeve for guiding the drill. The guiding sleeve has a first side facing the drill-rotating device and a second side intended to face the jaw bone during a drilling operation. A guiding through-hole extends from the first side to the second side. A rim also extends at least partly around the circumference of the drill, and the system comprises a drill stop sleeve provided with a recess extending circumferentially around an inner side of the drill stop sleeve, allowing the drill stop sleeve to be snap-locked onto the drill. The guiding sleeve also comprises a flange that defines an end position for the drill stop sleeve.
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: October 2, 2018
    Assignee: Elos Medtech Timmersdala AB
    Inventors: Mattias Lantz, Per-Olof Karlsson
  • Patent number: 10022206
    Abstract: A method, system, and dental prosthesis are provided to facilitate simulation of the natural appearance of teeth. The prosthesis can be formed to include a component to which an aesthetic coating, such as a coloring or tint, can be applied. Further, the prosthesis can include a porcelain coating disposed on the outer surface thereof, and on top of the aesthetic coating, such that the aesthetic coating can be visible through the porcelain coating of the prosthesis. During production, the crown can be coated with a metal and/or ceramic powder by means of a powder printer that can be controlled by computer equipment. A practical and rapid application function can be obtained to produce an extremely natural-looking result.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: July 17, 2018
    Assignee: Nobel Biocare Services AG
    Inventors: Per-Olof Karlsson, Urban Nilsson
  • Patent number: 10016255
    Abstract: The invention concerns a dental surgery device (1), comprising a punching member (15) having a cutting end part (16) suitable for removal of tissue on a jaw bone of a patient, and a guiding sleeve (7) for guiding the punching member (15) during a punching operation. The guiding sleeve (7) has a first side (8) intended to face away from the jaw bone and a second side (9) intended to face towards the jaw bone during a punching operation, and a guiding through-hole (101) extends from the first side (8) to the second side (9). The punching member (15) is adapted to fit into the guiding through-hole (101) such as to allow guidance by the guiding sleeve (7) when the punching member (15) is moved in an axial direction through the guiding through-hole (101).
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: July 10, 2018
    Assignee: Elos Medtech Timmersdala AB
    Inventors: Mattias Lantz, Per-Olof Karlsson